Belarus Pharmaceuticals and Helathcare Report Q3

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Arterium Corporation (GFARM) - Financial and Strategic SWOT Analysis Review

Arterium Corporation (GFARM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

Summary Arterium Corporation (Arterium) is a pharmaceutical company. The company develops, manufactures and markets pharmaceuticals, and antibacterial and herbal based medications. Its products include acelysin, acetylsalicylic acid, alteyca galychpharm, ambroxol, kanamycin, nicergolin, nifuroxazide, ...

Industries: Drug and Medication | Countries: Ukraine, Uzbekistan, Kazakhstan, Azerbaijan, Russian Federation, Belarus

Belarus Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Belarus Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • October 2014
  • 87 pages

BMI View: All indicators point to a period of prolonged economic and political upheaval in Belarus, with the pharmaceutical industry battered by a combination of high inflation and currency devaluation through to the end of the year. The industry retains significant long-term growth potential, although ...

Industries: Drug and Medication | Countries: Belarus

Belarus Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Belarus Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • June 2014
  • 83 pages

BMI View: The pharmaceutical industry in Belarus has significant long-term growth potential, but the country’s economy has entered a period of acute crisis and its long-deferred day of reckoning may finally have arrived. As of early June, the country’s pharmaceutical market faced a dire short- to ...

Industries: Drug and Medication | Countries: Belarus

Belarus Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Belarus Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • March 2014
  • 84 pages

Includes 3 FREE quarterly updates BMI View: We continue to believe the Belarusian pharmaceutical industry has long-term potential due to the country’s favourable geographic position, demographic profile and low per capita spending. Nonetheless, BMI foresees continued deterioration in the country’s ...

Industries: Drug and Medication | Countries: Belarus

Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in Belarus

Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in Belarus

  • $ 898
  • Industry report
  • by Euromonitor International
  • March 2014
  • 35 pages

The performance of the area usually depends on the severity of the winter and autumn seasons. The fact that there was a major cold and flu epidemic in Belarus in autumn 2009 and winter 2010 boosted demand within the area during 2010. Combination products and cough remedies continued to lead... Euromonito ...

Industries: Drug and Medication | Countries: Belarus

Analgesics Market Analysis in Belarus

Analgesics Market Analysis in Belarus

  • $ 898
  • Industry report
  • by Euromonitor International
  • March 2014
  • 32 pages

Combination products, mainly with vitamin C added, were widely used as analgesics and cold and flu treatments, with demand being boosted by the self-medication trend. Euromonitor International's report offers a comprehensive guide to the size and shape of the industry at a national level. It provides ...

Industries: Drug and Medication | Countries: Belarus

Belarus Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Belarus Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • January 2014
  • 91 pages

BMI View: The Belarusian pharmaceutical industry has strong long-term potential given its position bordering the EU and Russia, its demographic profile and still low per capita spending on pharmaceuticals. However, over the next 12-18 months the industry faces a rocky transition as the country surrenders ...

Industries: Drug and Medication | Countries: Belarus

NRT Smoking Cessation Aids Market Analysis in Belarus

NRT Smoking Cessation Aids Market Analysis in Belarus

  • $ 898
  • Industry report
  • by Euromonitor International
  • July 2013
  • 29 pages

billion sticks in Belarus in 2009. Whilst the number of male and female smokers dropped slightly, over two million people in the country continue to smoke. The number of male smokers in 2009 was more than five times higher than the number of female smokers, with 48% of men in the country and just 8% ...

Industries: Drug and Medication | Countries: Belarus

Ear Care Market Analysis in Belarus

Ear Care Market Analysis in Belarus

  • $ 898
  • Industry report
  • by Euromonitor International
  • July 2013
  • 35 pages

billion. As in eye care, consumers suffering from ear ailments typically prefer to seek advice from a doctor instead of self-medicating, with doctors often recommending more expensive but more effective remedies with fewer side effects. The fact that consumers typically use Rx medication to treat ea ...

Industries: Drug and Medication | Countries: Belarus

MarketVIEW: Tick-borne Encephalitis vaccines

MarketVIEW: Tick-borne Encephalitis vaccines

  • $ 7 995
  • Industry report
  • by VacZine Analytics Group Of Assay Advantage Ltd
  • September 2010
  • 55 pages

Tick-borne encephalitis (TBE) virus is the causative agent of tick-borne encephalitis (TBE), a potentially fatal neurological infection. The virus is transmitted to humans through the bite of infected Ixodes tick species which are endemic to a large area stretching from Southern Germany, across Russia ...

Industries: Drug and Medication | Countries: Russian Federation, Germany, Europe, Switzerland, Sweden, Slovakia (slovak Republic), Poland, Hungary, Croatia, Belarus, Japan, World

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.